Heart Transplantation

  • Shamel Abd-Allah
  • Paul A. Checchia
Chapter
First Online:

Keywords

Congenital Heart Disease Acute Rejection Pediatric Intensive Care Unit Continuous Renal Replacement Therapy Cardiac Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41(48):1271–1274.PubMedGoogle Scholar
  2. 2.
    Kantrowitz A, Haller JD, Joos H, et al. Transplantation of the heart in an infant and an adult. Am J Cardiol 1968;22(6):782–790.PubMedCrossRefGoogle Scholar
  3. 3.
    Oyer PE, Stinson EB, Reitz BA, et al. Cardiac transplantation: 1980. Transplant Proc 1981;13(1 Pt 1):199–206.Google Scholar
  4. 4.
    Burch M, Aurora P. Current status of paediatric heart, lung, and heart–lung transplantation. Arch Dis Child 2004;89(4):386–389.PubMedCrossRefGoogle Scholar
  5. 5.
    Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report—2004. J Heart Lung Transplant 2004;23(7):804–815.PubMedCrossRefGoogle Scholar
  6. 6.
    Boucek MM, Edwards LB, Keck BM, et al. Registry for the International Society for Heart and Lung Transplantation: Seventh Official Pediatric Report—2004. J Heart Lung Transplant 2004;23(6):933–947.PubMedCrossRefGoogle Scholar
  7. 7.
    Fricker FJ, Addonizio L, Bernstein D, et al. Heart transplantation in children: indications. Report of the Ad Hoc Subcommittee of the Pediatric Committee of the American Society of Transplantation (AST). Pediatr Transplant 1999;3(4):333–342.PubMedCrossRefGoogle Scholar
  8. 8.
    Donkin M, Kolovos NS, Checchia PA. The effect of specialized pediatric management on organ recovery from potential pediatric transplant donors. Crit Care Med 2004;32(12 Suppl):82.Google Scholar
  9. 9.
    Bailey LL, Nehlsen-Cannarella SL, Doroshow RW, et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med 1986;315(15):949–951.PubMedGoogle Scholar
  10. 10.
    Reitz BA, Jamieson SW, Gaudiani VA, et al. Method for cardiac transplantation in corrected transposition of the great arteries. J Cardiovasc Surg 1982;23(4):293–296.Google Scholar
  11. 11.
    Fricker FJ, Griffith BP, Hardesty RL, et al. Experience with heart transplantation in children. Pediatrics 1987;79(1):138–146.PubMedGoogle Scholar
  12. 12.
    Jamieson SW, Gaudiani VA, Reitz BA, et al. Operative treatment of an unresectable tumor of the left ventricle. J Thorac Cardiovasc Surg 1981;81(5):797–799.PubMedGoogle Scholar
  13. 13.
    Cooley DA, Frazier OH, Van Buren CT, et al. Cardiac transplantation in an 8-month-old female infant with subendocardial fibroelastosis. JAMA 1986;256(10):1326–1329.PubMedCrossRefGoogle Scholar
  14. 14.
    Checchia PA, Larsen R, Sehra R, et al. Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome. Ann Thorac Surg 2004;77(2):477–483.PubMedCrossRefGoogle Scholar
  15. 15.
    Quintessenza JA, Morell VO, Jacobs JP. Achieving a balance in the current approach to the surgical treatment of hypoplastic left heart syndrome. Cardiol Young 2004;(14 Suppl 1):127–130.PubMedGoogle Scholar
  16. 16.
    Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States [see comment]. N Engl J Med 2003;348(17):1647–1655.PubMedCrossRefGoogle Scholar
  17. 17.
    Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia [see comment]. N Engl J Med 2003;348(17):1639–1646.PubMedCrossRefGoogle Scholar
  18. 18.
    Arola A, Tuominen J, Ruuskanen O, et al. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 1998;101(3 Pt 1):369–376.PubMedCrossRefGoogle Scholar
  19. 19.
    Lewis AB. Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy. Am Heart J 1999;138(2 Pt 1):334–338.PubMedCrossRefGoogle Scholar
  20. 20.
    Erickson KW, Costanzo-Nordin MR, O’Sullivan EJ, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 1990;9(5):526–537.PubMedGoogle Scholar
  21. 21.
    Gajarski RJ, Mosca RS, Ohye RG, et al. Use of extracorporeal life support as a bridge to pediatric cardiac transplantation. J Heart Lung Transplant 2003;22(1):28–34.PubMedCrossRefGoogle Scholar
  22. 22.
    Vossler MR, Ni H, Toy W, et al. Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. J Heart Lung Transplant 2002;21(8):874–881.PubMedCrossRefGoogle Scholar
  23. 23.
    Burch M, Siddiqi SA, Celermajer DS, et al. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 1994;72(3):246–250.PubMedCrossRefGoogle Scholar
  24. 24.
    Tsirka AE, Trinkaus K, Chen SC, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004;44(2):391–397.PubMedCrossRefGoogle Scholar
  25. 25.
    Fiser WP, Yetman AT, Gunselman RJ, et al. Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation. J Heart Lung Transplant 2003;22(7):770–777.PubMedCrossRefGoogle Scholar
  26. 26.
    Levi D, Marelli D, Plunkett M, et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant 2002;21(7):760–770.PubMedCrossRefGoogle Scholar
  27. 27.
    Merkle F, Boettcher W, Stiller B, et al. Pulsatile mechanical cardiac assistance in pediatric patients with the Berlin heart ventricular assist device. J Extra-Corpor Technol 2003;35(2):115–120.PubMedGoogle Scholar
  28. 28.
    Pennington DG, Smedira NG, Samuels LE, et al. Mechanical circulatory support for acute heart failure. Ann Thorac Surg 2001;71(3 Suppl):S56–S85.PubMedCrossRefGoogle Scholar
  29. 29.
    Ishino K, Weng Y, Alexi-Meskishvili V, et al. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in children. Artif Organs 1996;20(6):728–732.PubMedCrossRefGoogle Scholar
  30. 30.
    Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999;23(11):979–983.PubMedCrossRefGoogle Scholar
  31. 31.
    Huang J, Trinkaus K, Huddleston CB, et al. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant 2004;23(6):716–722.PubMedCrossRefGoogle Scholar
  32. 32.
    Rosenthal DN, Dubin AM, Chin C, et al. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant 2000;19(8):751–755.PubMedCrossRefGoogle Scholar
  33. 33.
    Hetzer R, Loebe M, Potapov EV, et al. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children [see comment]. Ann Thorac Surg 1998;66(5):1498–1506.PubMedCrossRefGoogle Scholar
  34. 34.
    Ishino K, Loebe M, Uhlemann F, et al. Circulatory support with paracorporeal pneumatic ventricular assist device (VAD) in infants and children. Eur J Cardio-Thorac Surg 1997;11(5):965–972.CrossRefGoogle Scholar
  35. 35.
    Konertz W, Hotz H, Schneider M, et al. Clinical experience with the MEDOS HIA–VAD system in infants and children: a preliminary report. Ann Thorac Surg 1997;63(4):1138–1144.PubMedCrossRefGoogle Scholar
  36. 36.
    Laliberte E, Cecere R, Tchervenkov C, et al. The combined use of extracorporeal life support and the Berlin Heart pulsatile pediatric ventricular assist device as a bridge to transplant in a toddler. J Extra-Corpor Technol 2004;36(2):158–161.PubMedGoogle Scholar
  37. 37.
    Samuels L. Biventricular mechanical replacement. Surg Clin North Am 2004;84(1):309–321.PubMedCrossRefGoogle Scholar
  38. 38.
    Stiller B, Hetzer R, Weng Y, et al. Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant 2003;22(11):1201–1208.PubMedCrossRefGoogle Scholar
  39. 39.
    Taenaka Y, Takano H, Noda H, et al. Experimental evaluation and clinical application of a pediatric ventricular assist device. ASAIO Trans 1989;35(3):606–608.PubMedGoogle Scholar
  40. 40.
    Throckmorton AL, Allaire PE, Gutgesell HP, et al. Pediatric circulatory support systems. ASAIO J 2002;48(3):216–221.PubMedCrossRefGoogle Scholar
  41. 41.
    Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339(21):1522–1533.PubMedCrossRefGoogle Scholar
  42. 42.
    Young JB, Hauptman PJ, Naftel DC, et al. Determinants of early graft failure following cardiac transplantation, a 10-year, multi-institutional, multivariable analysis. J Heart Lung Transplant 2001;20(2):212.PubMedCrossRefGoogle Scholar
  43. 43.
    Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1987;76(5 Pt 2):V52–V55.PubMedGoogle Scholar
  44. 44.
    Gajarski RJ, Towbin JA, Bricker JT, et al. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol 1994;23(7):1682–1687.PubMedGoogle Scholar
  45. 45.
    Zales VR, Pahl E, Backer CL, et al. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. J Heart Lung Transplant 1993;12(6 Pt 1):965–973.PubMedGoogle Scholar
  46. 46.
    Anker SD, Clark AL, Teixeira MM, et al. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999;83(4):612–615.PubMedCrossRefGoogle Scholar
  47. 47.
    Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115(3):836–847.PubMedCrossRefGoogle Scholar
  48. 48.
    Ponikowski P, Piepoli M, Chua TP, et al. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure [see comment]. Eur Heart J 1999;20(22):1667–1675.PubMedCrossRefGoogle Scholar
  49. 49.
    Renlund DG, Taylor DO, Kfoury AG, et al. New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing. J Heart Lung Transplant 1999;18(11):1065–1070.PubMedCrossRefGoogle Scholar
  50. 50.
    Dosemeci L, Yilmaz M, Cengiz M, et al. Brain death and donor management in the intensive care unit: experiences over the last 3 years. Transplant Proc 2004;36(1):20–21.Google Scholar
  51. 51.
    Phongsamran PV. Critical care pharmacy in donor management. Prog Transplant 2004;14(2):105–113.PubMedGoogle Scholar
  52. 52.
    Sacristan-Lista F, Mosquera-Reboredo J, Vazquez-Martul E, et al. Influence of the management of asystolic donors on kidney transplantation outcome. Transplant Proc 2004;36(3):745–746.Google Scholar
  53. 53.
    Smith M. Physiologic changes during brain stem death–lessons for management of the organ donor. J Heart Lung Transplant 2004;23(9 Suppl):S217–S222.PubMedCrossRefGoogle Scholar
  54. 54.
    Cantin B, Kwok BW, Chan MC, et al. The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation 2003;76(9):1275–1279.PubMedCrossRefGoogle Scholar
  55. 55.
    Checchia PA, Sehra R, Moynihan J, et al. Myocardial injury in children following resuscitation after cardiac arrest. Resuscitation 2003;57(2):131–137.PubMedCrossRefGoogle Scholar
  56. 56.
    Grant JW, Canter CE, Spray TL, et al. Elevated donor cardiac troponin I. A marker of acute graft failure in infant heart recipients [erratum appears in Circulation 1995;91(12):3027]. Circulation 1994;90(6):2618–2621.PubMedGoogle Scholar
  57. 57.
    Potapov EV, Ivanitskaia EA, Loebe M, et al. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation 2001;71(10):1394–1400.PubMedCrossRefGoogle Scholar
  58. 58.
    Edwards JM, Hasz RD Jr, Robertson VM. Non-heart-beating organ donation: process and review. AACN Clinical Issues 1999;10(2):293–300.PubMedGoogle Scholar
  59. 59.
    Whetstine L, Bowman K, Hawryluck L. Pro/con ethics debate: is nonheart-beating organ donation ethically acceptable? Critical Care (Lond) 2002;6(3):192–195.CrossRefGoogle Scholar
  60. 60.
    DeVita MA, Snyder JV, Grenvik A. History of organ donation by patients with cardiac death. Kennedy Inst Ethics J 1993;3(2):113–129.PubMedGoogle Scholar
  61. 61.
    Del Rizzo DF, Menkis AH, Pflugfelder PW, et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant 1999;18(4):310–319.PubMedCrossRefGoogle Scholar
  62. 62.
    Bourge RC, Naftel DC, Costanzo-Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 1993;12(4):549–562.PubMedGoogle Scholar
  63. 63.
    Kobashigawa JA, Kirklin JK, Naftel DC, et al. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 1993;12(3):355–366.PubMedGoogle Scholar
  64. 64.
    de Begona JA, Gundry SR, Razzouk AJ, et al. Transplantation of hearts after arrest and resuscitation. Early and long-term results. J Thorac Cardiovasc Surg 1993;106(6):1196.PubMedGoogle Scholar
  65. 65.
    Mullen JC, Bentley MJ, Modry DL, et al. Extended donor ischemic times and recipient outcome after orthotopic cardiac transplantation. Can J Cardiol 2001;17(4):421–426.PubMedGoogle Scholar
  66. 66.
    Ott GY, Herschberger RE, Ratkovec RR, et al. Cardiac allografts from high-risk donors: excellent clinical results. Ann Thorac Surg 1994;57(1):76–82.PubMedGoogle Scholar
  67. 67.
    Pflugfelder PW, Singh NR, McKenzie FN, et al. Extending cardiac allograft ischemic time and donor age: effect on survival and long-term cardiac function. J Heart Lung Transplant 1991;10(3):394–400.PubMedGoogle Scholar
  68. 68.
    Kawauchi M, Gundry SR, de Begona JA, et al. Prolonged preservation of human pediatric hearts for transplantation: correlation of ischemic time and subsequent function. J Heart Lung Transplant 1993;12(1 Pt 1):55–58.PubMedGoogle Scholar
  69. 69.
    Kawauchi M, Gundry SR, Beierle F, et al. Myosin light chain efflux after heart transplantation in infants and children and its correlation with ischemic preservation time. J Thorac Cardiovasc Surg 1993;106(3):458–462.PubMedGoogle Scholar
  70. 70.
    Scheule AM, Zimmerman GJ, Johnston JK, et al. Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation 2002;106(12 Suppl 1):I163–I167.PubMedGoogle Scholar
  71. 71.
    Bhatia SJ, Kirshenbaum JM, Shemin RJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 1987;76(4):819–826.PubMedGoogle Scholar
  72. 72.
    Young JB, Leon CA, Short HD 3rd, et al. Evolution of hemodynamics after orthotopic heart and heart–lung transplantation: early restrictive patterns persisting in occult fashion. J Heart Lung Transplant 1987;6(1):34–43.Google Scholar
  73. 73.
    Vatner DE, Lavallee M, Amano J, et al. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog. Circ Res 1985;57(1):55–64.PubMedGoogle Scholar
  74. 74.
    Gilbert EM, Eiswirth CC, Mealey PC, et al. Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Circulation 1989;79(2):344–349.PubMedGoogle Scholar
  75. 75.
    Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report—2000. J Heart Lung Transplant 2000;19(10):909–931.PubMedCrossRefGoogle Scholar
  76. 76.
    Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001;38(4):923–931.PubMedCrossRefGoogle Scholar
  77. 77.
    Carrier M, Blaise G, Belisle S, et al. Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 1999;18(7):664–667.PubMedCrossRefGoogle Scholar
  78. 78.
    Girard C, Durand PG, Vedrinne C, et al. Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation [see comment]. J Cardiothorac Vasc Anesth 1993;7(4):481–485.PubMedCrossRefGoogle Scholar
  79. 79.
    Mosquera I, Crespo-Leiro MG, Tabuyo T, et al. Pulmonary hypertension and right ventricular failure after heart transplantation: usefulness of nitric oxide. Transplant Proc 2002;34(1):166–167.Google Scholar
  80. 80.
    Williams TJ, Salamonsen RF, Snell G, et al. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 1995;14(3):419–423.PubMedGoogle Scholar
  81. 81.
    Auler Junior JO, Carmona MJ, Bocchi EA, et al. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 1996;15(5):443–450.PubMedGoogle Scholar
  82. 82.
    Fenton KN, Webber SA, Danford DA, et al. Long-term survival after pediatric cardiac transplantation and postoperative ECMO support. Ann Thorac Surg 2003;76(3):843–847.PubMedCrossRefGoogle Scholar
  83. 83.
    Duncan BW. Extracorporeal life support for infants and children with cardiac disease. Overview and examples. In: Zwischenberger JB, Steinhorn RH, Bartlett RH, eds. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, 2nd ed.Google Scholar
  84. 84.
    Kirshbom PM, Bridges ND, Myung RJ, et al. Use of extracorporeal membrane oxygenation in pediatric thoracic organ transplantation. J Thorac Cardiovasc Surg 2002;123(1):130–136.PubMedCrossRefGoogle Scholar
  85. 85.
    Canter C, Naftel D, Caldwell R, et al. Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study. Circulation 1997;96(1):227–231.PubMedGoogle Scholar
  86. 86.
    Hoffman TM, Spray TL, Gaynor JW, et al. Survival after acute graft failure in pediatric thoracic organ transplant recipients. Pediatr Transplant 2000;4(2):112–117.PubMedCrossRefGoogle Scholar
  87. 87.
    Morgan JA, John R, Park Y, et al. Successful outcome with extended allograft ischemic time in pediatric heart transplantation. J Heart Lung Transplant 2005;24(1):58.PubMedCrossRefGoogle Scholar
  88. 88.
    Dearani JA, Razzouk AJ, Gundry SR, et al. Pediatric cardiac retransplantation: intermediate-term results. Ann Thorac Surg 2001;71(1):66–70.PubMedCrossRefGoogle Scholar
  89. 89.
    Collins KK, Thiagarajan RR, Chin C, et al. Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation. J Heart Lung Transplant 2003;22(10):1126–1133.PubMedCrossRefGoogle Scholar
  90. 90.
    Kertesz NJ, Towbin JA, Clunie S, et al. Long-term follow-up of arrhythmias in pediatric orthotopic heart transplant recipients: incidence and correlation with rejection. J Heart Lung Transplant 2003;22(8):889–893.PubMedCrossRefGoogle Scholar
  91. 91.
    Sanatani S, Chiu C, Nykanen D, et al. Evolution of heart rate control after transplantation: conduction versus autonomic innervation. Pediatr Cardiol 2004;25(2):113–118.PubMedCrossRefGoogle Scholar
  92. 92.
    Cannon BC, Denfield SW, Friedman RA, et al. Late pacemaker requirement after pediatric orthotopic heart transplantation may predict the presence of transplant coronary artery disease. J Heart Lung Transplant 2004;23(1):67–71.PubMedCrossRefGoogle Scholar
  93. 93.
    Chinnock RE, Torres VI, Jutzy RV, et al. Cardiac pacemakers in pediatric heart transplant recipients: incidence, indications, and associated factors. Pediatric Heart Transplant Group-Loma Linda. Pacing Clin Electrophysiol 1996;19(1):26–30.Google Scholar
  94. 94.
    Bauer J, Dapper F, Demirakca S, et al. Perioperative management of pulmonary hypertension after heart transplantation in childhood. J Heart Lung Transplant 1997;16(12):1238–1247.PubMedGoogle Scholar
  95. 95.
    Kimberling MT, Balzer DT, Hirsch R, et al. Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome. J Heart Lung Transplant 2002;21(4):455–459.PubMedCrossRefGoogle Scholar
  96. 96.
    Tamisier D, Vouhe P, Le Bidois J, et al. Donor-recipient size matching in pediatric heart transplantation: a word of caution about small grafts. J Heart Lung Transplant 1996;15(2):190–195.PubMedGoogle Scholar
  97. 97.
    Luckraz H, Charman SC, Parameshwar J, et al. Are non-brain stem–dead cardiac donors acceptable donors? J Heart Lung Transplant 2004;23(3):330.PubMedCrossRefGoogle Scholar
  98. 98.
    Bauer J, Thul J, Valeske K, et al. Pediatric management in pediatric heart transplantation. Thorac Cardiovasc Surg 2005;53(Suppl 2):S155–S158.PubMedCrossRefGoogle Scholar
  99. 99.
    Atz AM, Lefler AK, Fairbrother DL, et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 2002;124(3):628–629.PubMedCrossRefGoogle Scholar
  100. 100.
    Laquay N, Levy ML, Vaccaroni L, et al. Interet du sildenafil (Viagra) per os en cas d’hypertension arterielle pulmonaire apres chirurgie cardiaque pediatrique. Ann Fr Anesth Reanimation 2003;22(2):140–143.Google Scholar
  101. 101.
    Hallioglu O, Dilber E, Celiker A. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. Am J Cardiol 2003;92(8):1007–1009.PubMedCrossRefGoogle Scholar
  102. 102.
    Rimensberger PC, Spahr-Schopfer I, Berner M, et al. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 2001;103(4):544–548.PubMedGoogle Scholar
  103. 103.
    El-Banayosy NR, Arusoglu L, Kleikamp G, et al. Recovery of organ dysfunction during bridging to heart transplantation in children and adolescents. Int J Artif Organs 2003;26(5):395–400.PubMedGoogle Scholar
  104. 104.
    Blume ED. Current status of heart transplantation in children: update 2003. Pediatr Clin North Am 2003;50(6):1375–1391.PubMedCrossRefGoogle Scholar
  105. 105.
    Vricella LA, de Begona JA, Gundry SR, et al. Aggressive peritoneal dialysis for treatment of acute kidney failure after neonatal heart transplantation. J Heart Lung Transplant 1992;11(2 Pt 1):320–329.PubMedGoogle Scholar
  106. 106.
    Bunchman TE, McBryde KD, Mottes TE, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 2001;16(12):1067–1071.PubMedCrossRefGoogle Scholar
  107. 107.
    Stickle S, Brewer ED, Goldstein SL. Pediatric acute renal failure update: epidemiology and outcome from a three and one-half year experience [abstr]. J Am Soc Nephrol 2002;13:649.Google Scholar
  108. 108.
    Warady BA, Bunchman T. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000;15(1–2):11–13.PubMedCrossRefGoogle Scholar
  109. 109.
    Flynn JT. Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 2002;17(1):61–69.PubMedCrossRefGoogle Scholar
  110. 110.
    Hoffmann JN, Hartl WH, Deppisch R, et al. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995;48(5):1563–1570.PubMedCrossRefGoogle Scholar
  111. 111.
    Goldstein SL, Currier H, Graf C, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001;107(6):1309–1312.PubMedCrossRefGoogle Scholar
  112. 112.
    Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial [see comment]. Lancet 2000;356(9223):26–30.PubMedCrossRefGoogle Scholar
  113. 113.
    Alonso EM. Long-term renal function in pediatric liver and heart recipients. Pediatr Transplant 2004;8(4):381–385.PubMedCrossRefGoogle Scholar
  114. 114.
    English RF, Pophal SA, Bacanu SA, et al. Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. Am J Transplant 2002;2(8):769–773.PubMedCrossRefGoogle Scholar
  115. 115.
    Hornung TS, de Goede CG, O’Brien C, et al. Renal function after pediatric cardiac transplantation: the effect of early cyclosporine dosage. Pediatrics 2001;107(6):1346–1350.PubMedCrossRefGoogle Scholar
  116. 116.
    van Houten JP, Rothman A, Bejar R. High incidence of cranial ultrasound abnormalities in full-term infants with congenital heart disease. Am J Perinatol 1996;13(1):47–53.PubMedCrossRefGoogle Scholar
  117. 117.
    Ferry PC. Neurologic sequelae of open-heart surgery in children. An ‘‘irritating question.’’ Am J Dis Child 1990;144(3):369–373.PubMedGoogle Scholar
  118. 118.
    Baum M, Freier MC, Chinnock RE. Neurodevelopmental outcome of solid organ transplantation in children. Pediatr Clin North Am 2003;50(6):1493–1503.PubMedCrossRefGoogle Scholar
  119. 119.
    Menache CC, du Plessis AJ, Wessel DL, et al. Current incidence of acute neurologic complications after open-heart operations in children. Ann Thorac Surg 2002;73(6):1752–1758.PubMedCrossRefGoogle Scholar
  120. 120.
    Rappaport LA, Wypij D, Bellinger DC, et al. Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Boston Circulatory Arrest Study Group. Circulation 1998;97(8):773–779.PubMedGoogle Scholar
  121. 121.
    Lynch BJ, Glauser TA, Canter C, et al. Neurologic complications of pediatric heart transplantation. Arch Pediatr Adolesc Med 1994;148(9):973–979.PubMedGoogle Scholar
  122. 122.
    Martin AB, Bricker JT, Fishman M, et al. Neurologic complications of heart transplantation in children. J Heart Lung Transplant 1992;11(5):933–942.PubMedGoogle Scholar
  123. 123.
    Andropoulos DB, Stayer SA, Diaz LK, et al. Neurological monitoring for congenital heart surgery. Anesth Analg 2004;99(5):1365–1375.PubMedCrossRefGoogle Scholar
  124. 124.
    Cottrell SM, Morris KP, Davies P, et al. Early postoperative body temperature and developmental outcome after open heart surgery in infants. Ann Thorac Surg 2004;77(1):66–71.PubMedCrossRefGoogle Scholar
  125. 125.
    Faraci M, Lanino E, Dini G, et al. Severe neurologic complications after hematopoietic stem cell transplantation in children [erratum appears in Neurology 2003;60(6):1055]. Neurology 2002;59(12):1895–1904.PubMedCrossRefGoogle Scholar
  126. 126.
    Menegaux F, Keeffe EB, Andrews BT, et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 1994;58(4):447–450.PubMedCrossRefGoogle Scholar
  127. 127.
    Wong M, Mallory GB Jr, Goldstein J, et al. Neurologic complications of pediatric lung transplantation. Neurology 1999;53(7):1542–1549.PubMedGoogle Scholar
  128. 128.
    Al-Rasheed AK, Blaser SI, Minassian BA, et al. Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting [see comment]. Pediatr Neurol 2000;23(4):353–356.PubMedCrossRefGoogle Scholar
  129. 129.
    Schowengerdt KO Jr, Gajarski RJ, Denfield S. Progressive visual deterioration leading to blindness after pediatric heart transplantation. Texas Heart Inst J 1993;20(4):299–303.Google Scholar
  130. 130.
    Tweddle DA, Windebank KP, Hewson QC, et al. Cyclosporin neurotoxicity after chemotherapy [see comment]. BMJ 1999;318(7191):1113.PubMedGoogle Scholar
  131. 131.
    Taque S, Peudenier S, Gie S, et al. Central neurotoxicity of cyclosporine in two children with nephrotic syndrome. Pediatr Nephrol 2004;19(3):276–280.PubMedCrossRefGoogle Scholar
  132. 132.
    Staatz CE, Taylor PJ, Lynch SV, et al. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplant 2004;10(4):506–512.CrossRefGoogle Scholar
  133. 133.
    Kanter KR, Tam VK, Vincent RN, et al. Current results with pediatric heart transplantation. Ann Thorac Surg 1999;68(2):527–531.PubMedCrossRefGoogle Scholar
  134. 134.
    Groetzner J, Reichart B, Roemer U, et al. Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. Ann Thorac Surg 2005;79(1):53.PubMedCrossRefGoogle Scholar
  135. 135.
    Lamour JM, Hsu DT, Quaegebeur JM, et al. Heart transplantation to a physiologic single lung in patients with congenital heart disease. J Heart Lung Transplant 2004;23(8):948–953.PubMedCrossRefGoogle Scholar
  136. 136.
    Chinnock R, Baum M. Somatic growth in infant heart transplant recipients [see comment]. Pediatr Transplant 1998;2(1):30–34.PubMedGoogle Scholar
  137. 137.
    Wesley JR. Nutrient metabolism in relation to the systemic stress response. In: Fuhrman BP, Zimmerman JJ, eds. Pediatric Critical Care, 2nd. ed. St. Louis: Mosby; 1998:799–819.Google Scholar
  138. 138.
    Ngo K, Fry-Bowers E, Sehra R, et al. Inadequate caloric delivery in pediatric patients in intensive care unit settings. Crit Care Med 2001;29(12):A125.Google Scholar
  139. 139.
    Grewal RS, Mampilly J, Misra TR. Postoperative protein metabolism and electrolyte changes in pediatric surgery. Int Surg 1969;51(2):142–148.PubMedGoogle Scholar
  140. 140.
    Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr 1986;5(1):9–22.PubMedCrossRefGoogle Scholar
  141. 141.
    Wildhaber BE, Yang H, Spencer AU, et al. Lack of enteral nutrition—effects on the intestinal immune system. J Surg Res 2005;123(1):8.PubMedCrossRefGoogle Scholar
  142. 142.
    Sakopoulos AG, Gundry S, Razzouk AJ, et al. Cholelithiasis in infant and pediatric heart transplant patients. Pediatr Transplant 2002;6(3):231–234.PubMedCrossRefGoogle Scholar
  143. 143.
    Rakhit A, Nurko S, Gauvreau K, et al. Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant 2002;21(7):751.PubMedCrossRefGoogle Scholar
  144. 144.
    Seipelt IM, Crawford SE, Rodgers S, et al. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin. J Heart Lung Transplant 2004;23(3):317–322.PubMedCrossRefGoogle Scholar
  145. 145.
    Russo LM, Webber SA. Pediatric heart transplantation: immunosuppression and its complications. Curr Opin Cardiol 2004;19(2):104–109.PubMedCrossRefGoogle Scholar
  146. 146.
    Kirklin J, Chinnock RE, Pearce FB. Pediatric heart transplantation. In: Kirklin J, Young JB, McGiffin DC, eds. Heart Transplantation, 1st ed. Philadelphia: Churchill Livingston; 2002:717–770.Google Scholar
  147. 147.
    Leonard H, Hornung T, Parry G, et al. Pediatric cardiac transplant: results using a steroid-free maintenance regimen. Pediatr Transplant 2003;7(1):59–63.PubMedCrossRefGoogle Scholar
  148. 148.
    Zheng H, Webber S, Zeevi A, et al. The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Hum Immunol 2002;63(9):765–770.PubMedCrossRefGoogle Scholar
  149. 149.
    Pollock-BarZiv SM, Dipchand AI, McCrindle BW, et al. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up. J Heart Lung Tranplant 2005;24(2):190.CrossRefGoogle Scholar
  150. 150.
    Hathout EH, Chinnock RE, Johnston JK, et al. Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients. Am J Transplant 2003;3(8):994–998.PubMedCrossRefGoogle Scholar
  151. 151.
    Kobashigawa JA. Statins as immunosuppressive agents. Liver Transplant 2001;7(4):559–561.CrossRefGoogle Scholar
  152. 152.
    Jacobs JP, Quintessenza JA, Boucek RJ, et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 2004;78(5):1703–1709.PubMedCrossRefGoogle Scholar
  153. 153.
    Boucek MM. Breaching the barrier of ABO incompatibility in heart transplantation for infants [comment]. N Engl J Med 2001;344(11):843–844.PubMedCrossRefGoogle Scholar
  154. 154.
    Rao JN, Hasan A, Hamilton JR, et al. ABO-incompatible heart transplantation in infants: the Freeman Hospital experience. Transplantation 2004;77(9):1389–1394.PubMedCrossRefGoogle Scholar
  155. 155.
    West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants [see comment]. N Engl J Med 2001;344(11):793–800.PubMedCrossRefGoogle Scholar
  156. 156.
    Pahl E, Naftel DC, Canter CE, et al. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. J Heart Lung Transplant 2001;20(3):279–287.PubMedCrossRefGoogle Scholar
  157. 157.
    Chin C, Naftel DC, Singh TP, et al. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant 2004;23(2):178–185.PubMedCrossRefGoogle Scholar
  158. 158.
    Chinnock R, Sherwin T, Robie S, et al. Emergency department presentation and management of pediatric heart transplant recipients. Pediatr Emerg Care 1995;11(6):355–360.PubMedCrossRefGoogle Scholar
  159. 159.
    Johnston J, Mathis C. Determination of rejection using noninvasive parameters after cardiac transplantation in very early infancy: the Loma Linda experience. Progr Cardiovasc Nurs 1988;3(1):13–18.Google Scholar
  160. 160.
    Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart and Lung Transplantation. J Heart Transplant 1990;9(6):587–593.PubMedGoogle Scholar
  161. 161.
    Abramson LP, Pahl E, Huang L, et al. Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation [erratum appears in Transplantation 2002;73(2):321]. Transplantation 2002;73(1):153–156.PubMedCrossRefGoogle Scholar
  162. 162.
    Awad MR, Webber S, Boyle G, et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 2001;20(6):625–630.PubMedCrossRefGoogle Scholar
  163. 163.
    Lan YT, Chang RK, Alejos JC, et al. B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 2004;23(5):558–563.PubMedCrossRefGoogle Scholar
  164. 164.
    Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation [see comment]. N Eng J Med 2001;344(20):1498–1503.CrossRefGoogle Scholar
  165. 165.
    Oklu E, Bulutcu FS, Yalcin Y, et al. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine [see comment]. J Cardiothorac Vasc Anesth 2003;17(6):686–690.PubMedCrossRefGoogle Scholar
  166. 166.
    Jordan SC, Quartel AW, Czer LS, et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998;66(6):800–805.PubMedCrossRefGoogle Scholar
  167. 167.
    Pahl E, Crawford SE, Cohn RA, et al. Reversal of severe late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis. Am J Cardiol 2000;85(6):735–739.PubMedCrossRefGoogle Scholar
  168. 168.
    Asano M, Gundry SR, Razzouk AJ, et al. Total lymphoid irradiation for refractory rejection in pediatric heart transplantation. Ann Thorac Surg 2002;74(6):1979–1985.PubMedCrossRefGoogle Scholar
  169. 169.
    Ringewald JM, Gidding SS, Crawford SE, et al. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 2001;139(1):75–78.PubMedCrossRefGoogle Scholar
  170. 170.
    Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1990;119:538–544.Google Scholar
  171. 171.
    Mulla NF, Johnston JK, Vander Dussen L, et al. Late rejection is a predictor of transplant coronary artery disease in children. J Am Coll Cardiol 2001;37(1):243–250.PubMedCrossRefGoogle Scholar
  172. 172.
    Berry GJ, Rizeq MN, Weiss LM, et al. Graft coronary disease in pediatric heart and combined heart–lung transplant recipients: a study of fifteen cases. J Heart Lung Transplantation 1993;12(6 Pt 2):S309–S319.Google Scholar
  173. 173.
    Dent CL, Canter CE, Hirsch R, et al. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Transplant 2000;19(3):240–248.PubMedCrossRefGoogle Scholar
  174. 174.
    Costello JM, Wax DF, Binns HJ, et al. A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant 2003;22(1):44–49.PubMedCrossRefGoogle Scholar
  175. 175.
    Kuhn MA, Jutzy KR, Deming DD, et al. The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. J Am Coll Cardiol 2000;36(1):250–254.PubMedCrossRefGoogle Scholar
  176. 176.
    Di Filippo S, Semiond B, Roriz R, et al. Non-invasive detection of coronary artery disease by dobutamine-stress echocardiography in children after heart transplantation. J Heart Lung Transplant 2003;22(8):876–882.PubMedCrossRefGoogle Scholar
  177. 177.
    Larsen RL, Applegate PM, Dyar DA, et al. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children. J Am Coll Cardiol 1998;32(2):515–520.PubMedCrossRefGoogle Scholar
  178. 178.
    Razzouk AJ, Chinnock RE, Dearani JA, et al. Cardiac retransplantation for graft vasculopathy in children: should we continue to do it? Arch Surg 1998;133(8):881–885.PubMedCrossRefGoogle Scholar
  179. 179.
    Webber SA, Naftel DC, Parker J, et al. Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes. J Heart Lung Transplant 2003;22(8):869–875.PubMedCrossRefGoogle Scholar
  180. 180.
    Pahl E, Zales VR, Fricker FJ, et al. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation 1994;90(5 Pt 2):II56–II60.PubMedGoogle Scholar
  181. 181.
    Green M, Webber S. Posttransplantation lymphoproliferative disorders. Pediatr Clin North Am 2003;50(6):1471–1491.PubMedCrossRefGoogle Scholar
  182. 182.
    Zangwill SD, Hsu DT, Kichuk MR, et al. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant 1998;17(12):1161–1166.PubMedGoogle Scholar
  183. 183.
    Harwood JS, Gould FK, McMaster A, et al. Significance of Epstein-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation [see comment]. Pediatr Transplant 1999;3(2):100–103.PubMedCrossRefGoogle Scholar
  184. 184.
    Orentas RJ, Schauer DW Jr, Ellis FW, et al. Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients. Pediatr Transplant 2003;7(4):305–334.PubMedCrossRefGoogle Scholar
  185. 185.
    Schowengerdt KO, Naftel DC, Seib PM, et al. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group. J Heart Lung Transplant 1997;16(12):1207–1216.PubMedGoogle Scholar
  186. 186.
    Freier MC, Babikian T, Pivonka J, et al. A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation. J Heart Lung Transplant 2004;23(7):857–864.PubMedCrossRefGoogle Scholar
  187. 187.
    Baum M, Freier MC, Freeman K, et al. Developmental outcomes and cognitive functioning in infant and child heart transplant recipients. Progr Pediatr Cardiol 2000;11:159–163.CrossRefGoogle Scholar
  188. 188.
    Baum M, Freier MC, Freeman K, et al. Neuropsychological outcome of infant heart transplant recipients. J Pediatr 2004;145(3):365–372.PubMedCrossRefGoogle Scholar
  189. 189.
    Ikle L, Hale K, Fashaw L, et al. Developmental outcome of patients with hypoplastic left heart syndrome treated with heart transplantation [comment]. J Pediatr 2003;142(1):20–25.PubMedCrossRefGoogle Scholar
  190. 190.
    Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 1993;12(5):501–507.PubMedGoogle Scholar
  191. 191.
    Checchia PA, Sehra R, Daher N, et al. An examination of the incidence of intubation and mechanical ventilation beyond the peri-operative period in pediatric heart transplant recipients. J Heart Lung Transplant 2004;23(3):379–382.PubMedCrossRefGoogle Scholar
  192. 192.
    Gale GB. Pediatric stem cell transplantation and critical care (an outcome evaluation). Front Biosci 2001;6:G33–G37.PubMedCrossRefGoogle Scholar
  193. 193.
    Keenan HT, Bratton SL, Martin LD, et al. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med 2000;28(3):830–835.PubMedCrossRefGoogle Scholar
  194. 194.
    Schneiderman L, Jecker N, Jonsen A. Medical futility: Its meaning and clinical implications. Ann Intern Med 1990;112:949–954.PubMedGoogle Scholar
  195. 195.
    Huaringa AJ, Leyva FJ, Giralt SA, et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000;28(4):1014–1017.PubMedCrossRefGoogle Scholar
  196. 196.
    Afessa B, Gay PC, Plevak DJ, et al. Pulmonary complications of orthotopic liver transplantation. Mayo Clin Proc 1993;68(5):427–434.Google Scholar
  197. 197.
    Afessa B, Tefferi A, Hoagland HC, et al. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 1992;67(2):117–122.Google Scholar
  198. 198.
    Dawkins KD, Jamieson SW, Hunt SA, et al. Long-term results, hemodynamics, and complications after combined heart and lung transplantation. Circulation 1985;71(5):919–926.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2009

Authors and Affiliations

  • Shamel Abd-Allah
    • 1
  • Paul A. Checchia
    • 2
  1. 1.Associate Professor of Pediatrics Director, Division of Critical Care MedicineLoma Linda University School of Medicine Loma Linda University Children’s HospitalLoma LindaUSA
  2. 2.Assistant Professor of Critical Care and Cardiology Director, Pediatric Cardiac Intensive Care ProgramWashington University School of Medicine Co-Director, Pediatric Intensive Care Unit St. Louis Children’s HospitalSt. LouisUSA

Personalised recommendations